These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7623771)

  • 1. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
    Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R
    Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
    Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
    Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor.
    Boer R; Dichtl M; Borchers C; Ulrich WR; Marecek JF; Prestwich GD; Glossmann H; Striessnig J
    Biochemistry; 1996 Feb; 35(5):1387-96. PubMed ID: 8634268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein.
    Boer R; Ulrich WR; Haas S; Borchers C; Gekeler V; Boss H; Przybylski M; Schödl A
    Eur J Pharmacol; 1996 Jan; 295(2-3):253-60. PubMed ID: 8720592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D; Boer R; Callaghan R; Ulrich WR
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance.
    Hofmann J; Gekeler V; Ise W; Noller A; Mitterdorfer J; Hofer S; Utz I; Gotwald M; Boer R; Glossmann H
    Biochem Pharmacol; 1995 Mar; 49(5):603-9. PubMed ID: 7887974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
    Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
    Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
    Vaughan RA
    Mol Pharmacol; 1995 May; 47(5):956-64. PubMed ID: 7746282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
    Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
    Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
    Nare B; Prichard RK; Georges E
    Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of photogenerated site-directed free radicals on surface dihydropyridine binding sites identified with photoaffinity probe (-)-[3H]-azidopine on cultured monkey renal cells.
    Drímal J; Bohácik L
    Methods Find Exp Clin Pharmacol; 1994; 16(6):397-404. PubMed ID: 7530790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of the forskolin labeling sites to both halves of P-glycoprotein: similarity of the sites labeled by forskolin and prazosin.
    Morris DI; Greenberger LM; Bruggemann EP; Cardarelli C; Gottesman MM; Pastan I; Seamon KB
    Mol Pharmacol; 1994 Aug; 46(2):329-37. PubMed ID: 7915819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexniguldipine-HCl is a potent allosteric inhibitor of [3H]vinblastine binding to P-glycoprotein of CCRF ADR 5000 cells.
    Malkhandi J; Ferry DR; Boer R; Gekeler V; Ise W; Kerr DJ
    Eur J Pharmacol; 1994 Dec; 288(1):105-14. PubMed ID: 7705462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
    Wang Y; Georges E
    Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoaffinity labeling and purification of ZG-16p, a high-affinity dihydropyridine binding protein of rat pancreatic zymogen granule membranes that regulates a K(+)-selective conductance.
    Braun M; Thévenod F
    Mol Pharmacol; 2000 Feb; 57(2):308-16. PubMed ID: 10648640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
    Smith CD; Zilfou JT; Stratmann K; Patterson GM; Moore RE
    Mol Pharmacol; 1995 Feb; 47(2):241-7. PubMed ID: 7870031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
    Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A molecular basis for multidrug resistance and reversal of the resistance].
    Akiyama S; Yoshimura A; Kikuchi H; Kamiwatari M; Nagata Y; Seto K; Sakota R; Utsunomiya A; Hanada S; Hashimoto S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1266-72. PubMed ID: 2567148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.